<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Remedies Limited has filed its annual disclosure to BSE confirming that it does not qualify as a 'Large Corporate' under SEBI's criteria dated August 10, 2021. The disclosure covers the 2-year block period of FY 2024-25 and FY 2025-26. All borrowing-related fields, including incremental borrowing, mandatory debt securities borrowing, and shortfall details, are reported as 'Not Applicable.' No penalty is applicable from the previous block. The filing is signed by Company Secretary Aditya Patel and CFO/Whole-time Director Parth Chandulal Kothia.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms the company's borrowing levels remain well below the SEBI Large Corporate threshold.